Background: Hemodialysis therapy for end-stage kidney disease (ESKD) requires suitable vascular access, most commonly the arteriovenous fistula (AVF). Forty percent of AVFs fail within one year, leading to morbidity and care cost... ...

请注册登录后继续浏览